Alkermes plc. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Alkermes plc. (ALKS) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five of $46.16 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue · last filed 2026-07-28
- 2026-06-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $46.16M.
- 2026-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $72.75M.
- 2025-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $94.97M.
- 2025-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five $274.10M.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five as first filed |
|---|---|---|
| 2026-06-30 | $46.16M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $72.75M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $94.97M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $274.10M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $248.18M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $236.88M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $207.96M 10-K · filed 2025-02-12 | |
| 2024-09-30 | $217.44M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $183.82M 10-Q · filed 2024-07-24 | |
| 2024-03-31 | $162.54M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $148.14M 10-K · filed 2024-02-21 | |
| 2023-09-30 | $133.93M 10-Q · filed 2023-10-25 | |
| 2023-06-30 | $76.31M 10-Q · filed 2023-07-26 | |
| 2023-03-31 | $100.51M 10-Q · filed 2023-04-26 | |
| 2022-12-31 | $131.79M 10-K · filed 2023-02-16 | |
| 2022-09-30 | $166.98M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $180.17M 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $228.00M 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $248.79M 10-K · filed 2022-02-16 | |
| 2021-09-30 | $257.11M 10-Q · filed 2021-10-27 | |
| 2021-06-30 | $212.19M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $179.47M 10-Q · filed 2021-04-28 | |
| 2020-12-31 | $140.81M 10-K · filed 2021-02-11 | |
| 2020-09-30 | $130.86M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $106.15M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $145.43M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $190.25M 10-K · filed 2020-02-13 | |
| 2019-09-30 | $110.63M 10-Q · filed 2019-10-23 | |
| 2019-06-30 | $138.29M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $183.14M 10-Q · filed 2019-04-25 | |
| 2018-12-31 | $164.86M 10-K · filed 2019-02-15 | |
| 2018-09-30 | $146.78M 10-Q · filed 2018-10-23 | |
| 2018-06-30 | $149.80M 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $136.85M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $161.47M 10-K · filed 2018-02-16 | |
| 2017-09-30 | $149.01M 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $118.02M 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $126.66M 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $147.07M 10-K · filed 2017-02-17 | |
| 2016-09-30 | $165.83M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $138.75M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $260.76M 10-Q · filed 2016-04-28 | |
| 2015-12-31 | $286.74M 10-K · filed 2016-02-25 | |
| 2015-09-30 | $235.28M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $291.48M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $260.55M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $252.49M 10-K · filed 2015-02-24 | |
| 2014-09-30 | $278.41M 10-Q · filed 2014-10-29 | |
| 2014-06-30 | $226.66M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $290.91M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $142.40M 10-KT · filed 2014-02-27 | |
| 2013-09-30 | $115.61M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $120.48M 10-Q · filed 2013-07-25 | |
| 2013-03-31 | $124.42M 10-K · filed 2013-05-23 | |
| 2012-09-30 | $69.99M 10-Q · filed 2013-01-31 | $44.06M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $78.84M 10-Q · filed 2012-07-26 | |
| 2012-03-31 | $93.16M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |